Defining Extended Spectrum β-Lactamases: Implications of Minimum Inhibitory Concentration-Based Screening Versus Clavulanate Confirmation Testing
Crossref DOI link: https://doi.org/10.1007/s40121-015-0094-6
Published Online: 2015-10-20
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sutherland, Christina A.
Crandon, Jared L.
Nicolau, David P.
Funding for this research was provided by:
Cubist Pharmaceuticals